imatinib mesylate has been researched along with Anguilluliasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, P; Bota, S; Constantino, C; Maia, R | 1 |
| Jeon, J; Koh, YI; Ryang, DW; Won, EJ | 1 |
2 other study(ies) available for imatinib mesylate and Anguilluliasis
| Article | Year |
|---|---|
Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.
Topics: Adrenal Cortex Hormones; Africa; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Bone Diseases; Child, Preschool; Drug Combinations; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Ivermectin; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Rare Diseases; Receptor, Platelet-Derived Growth Factor alpha; Strongyloides stercoralis; Strongyloidiasis; Treatment Outcome | 2019 |
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy.
Topics: Aged; Albendazole; Animals; Diabetes Mellitus, Type 2; Eosinophilia; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Steroids; Strongyloides stercoralis; Strongyloidiasis | 2015 |